Fig. 6From: System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinomaThe screened drugs for PAAD treatment. IC 50 value of A.443654 (A), PD 173,074 (C), Epothilone. B (E), Lapatinib (G) in high-and low-risk patients with PAAD. The corresponding 3D structures are shown in (B), (D), (F) and (H), respectivelyBack to article page